The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:

EuroIntervention 2006;2:286-294 - DOI10.4244/EIJV2I3A53.

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Green Lane Cardiovascular Service, Auckland, New Zealand; 3. Herzzentrum, Kassel, Germany; 4. Academisch Medisch Centrum, Amsterdam, The Netherlands; 5. Max Heart and Vascular Institu

Background: Everolimus has been successfully tested in humans using both an erodable and a durable polymer in small previous studies.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions